Suppr超能文献

口服和外用色甘酸钠治疗婴儿弥漫性皮肤肥大细胞增多症

Oral and topical sodium cromoglicate in the treatment of diffuse cutaneous mastocytosis in an infant.

作者信息

Edwards Alan Martin, Capková Stepánka

机构信息

The David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Newport, Isle Of Wight, UK.

出版信息

BMJ Case Rep. 2011 Jun 29;2011:bcr0220113910. doi: 10.1136/bcr.02.2011.3910.

Abstract

Diffuse cutaneous mastocytosis (DCM) is a rare, severe, variant of cutaneous mastocytosis. The authors report the case of a male infant who developed maculae and maculopapulae on his legs and abdomen when aged 3.5 months, which spread to all body surfaces within weeks. Diagnosis of DCM was made at the age of 6 months when he had developed extensive bullous eruptions, generalised pruritus, flushing and abdominal pain. Treatment was started with oral dimethindine maleate. At the age of 18 months, oral sodium cromoglicate (SCG) was introduced. At the age of 23 months, additional treatment was started with a cutaneous emulsion containing 4% SCG. Continued treatment with oral dimethindine maleate, oral SCG with the dose maintained at 25 mg/kg/day, and SCG 4% cutaneous emulsion applied two to four times daily has resulted in a steady improvement of symptoms and skin appearance.

摘要

弥漫性皮肤肥大细胞增多症(DCM)是皮肤肥大细胞增多症的一种罕见、严重的变异型。作者报告了一例男婴病例,该男婴在3.5个月大时腿部和腹部出现斑疹和斑丘疹,数周内蔓延至全身。6个月大时,当他出现广泛的大疱性皮疹、全身性瘙痒、潮红和腹痛时,被诊断为DCM。治疗开始时使用口服马来酸氯苯那敏。18个月大时,开始使用口服色甘酸钠(SCG)。23个月大时,开始额外使用含4%SCG的皮肤乳剂进行治疗。持续使用口服马来酸氯苯那敏、将口服SCG剂量维持在25mg/kg/天,并每天使用2至4次4%SCG皮肤乳剂进行治疗,使症状和皮肤外观得到了稳步改善。

相似文献

1
Oral and topical sodium cromoglicate in the treatment of diffuse cutaneous mastocytosis in an infant.
BMJ Case Rep. 2011 Jun 29;2011:bcr0220113910. doi: 10.1136/bcr.02.2011.3910.
2
Bullous mastocytosis treated with oral betamethasone therapy.
Indian J Pediatr. 2004 Mar;71(3):261-3. doi: 10.1007/BF02724280.
4
A randomised, controlled trial of a 4% cutaneous emulsion of sodium cromoglicate in treatment of atopic dermatitis in children.
J Dermatolog Treat. 2015 Jun;26(3):291-6. doi: 10.3109/09546634.2014.946380. Epub 2014 Aug 7.
5
Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus.
Br J Dermatol. 2010 Mar;162(3):674-6. doi: 10.1111/j.1365-2133.2009.09516.x. Epub 2009 Sep 24.
6
Suplatast tosilate for treating cutaneous mastocytosis.
Pediatr Dermatol. 2015 May-Jun;32(3):e118-9. doi: 10.1111/pde.12552. Epub 2015 Mar 17.
7
Oral and inhaled sodium cromoglicate in the management of systemic mastocytosis: a case report.
J Med Case Rep. 2010 Jun 26;4:193. doi: 10.1186/1752-1947-4-193.
8
Neonatal onset diffuse cutaneous mastocytosis: a case report and review of the literature.
Pediatr Dermatol. 2011 Sep-Oct;28(5):542-6. doi: 10.1111/j.1525-1470.2010.01212.x. Epub 2010 Jul 29.
9
Diffuse cutaneous mastocytosis: analysis of 10 cases and a brief review of the literature.
J Eur Acad Dermatol Venereol. 2012 Dec;26(12):1565-71. doi: 10.1111/j.1468-3083.2011.04350.x. Epub 2011 Nov 18.
10
A widespread blistering eruption: diffuse cutaneous mastocytosis.
Dermatol Online J. 2023 Dec 15;29(6). doi: 10.5070/D329663004.

引用本文的文献

2
Trials and Treatments: An Update on Pharmacotherapy for Idiopathic Pulmonary Fibrosis.
Life (Basel). 2023 Feb 10;13(2):486. doi: 10.3390/life13020486.
3
Pediatric Mastocytosis: An Update.
Mediterr J Hematol Infect Dis. 2021 Nov 1;13(1):e2021069. doi: 10.4084/MJHID.2021.069. eCollection 2021.
4
Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.
Int J Mol Sci. 2021 Mar 4;22(5):2586. doi: 10.3390/ijms22052586.
5
The Evaluation of Concentration - In-Vitro Release Relationship for Topical Semisolid Formulations of Sodium Cromoglycate.
Curr Health Sci J. 2015 Oct-Dec;41(4):368-374. doi: 10.12865/CHSJ.41.04.12. Epub 2015 Dec 22.
6
Diffuse cutaneous mastocytosis with novel somatic KIT mutation K509I and association with tuberous sclerosis.
Clin Case Rep. 2018 Jul 31;6(9):1834-1840. doi: 10.1002/ccr3.1607. eCollection 2018 Sep.
7
Mastocytosis in Children.
Curr Allergy Asthma Rep. 2017 Oct 7;17(11):80. doi: 10.1007/s11882-017-0748-4.
8
Mastocytosis: from a Molecular Point of View.
Clin Rev Allergy Immunol. 2018 Jun;54(3):397-411. doi: 10.1007/s12016-017-8619-2.
10
Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes.
F1000Res. 2016 Nov 14;5:2666. doi: 10.12688/f1000research.9565.1. eCollection 2016.

本文引用的文献

1
Systemic absorption of sodium cromoglicate from a new cutaneous emulsion (Altoderm ®) in children with atopic dermatitis.
Eur J Dermatol. 2010 Nov-Dec;20(6):864-5. doi: 10.1684/ejd.2010.1101. Epub 2010 Oct 19.
2
G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium.
Pharmacology. 2010;86(1):1-5. doi: 10.1159/000314164. Epub 2010 Jun 19.
3
Effect of oral cromolyn sodium on CKD-associated pruritus and serum tryptase level: a double-blind placebo-controlled study.
Nephrol Dial Transplant. 2010 May;25(5):1541-7. doi: 10.1093/ndt/gfp628. Epub 2009 Dec 10.
4
Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus.
Br J Dermatol. 2010 Mar;162(3):674-6. doi: 10.1111/j.1365-2133.2009.09516.x. Epub 2009 Sep 24.
5
Mastocytosis in children: a protocol for management.
Pediatr Dermatol. 2008 Jul-Aug;25(4):493-500. doi: 10.1111/j.1525-1470.2008.00738.x.
6
Mastocytosis: a rare case of anaphylaxis in paediatric age and literature review.
Allergol Immunopathol (Madr). 2008 May-Jun;36(3):154-63.
7
Cutaneous mastocytosis: a review focusing on the pediatric population.
Clin Pediatr (Phila). 2008 Oct;47(8):757-61. doi: 10.1177/0009922808318344. Epub 2008 May 23.
9
Mastocytosis: current concepts in diagnosis and treatment.
Ann Hematol. 2002 Dec;81(12):677-90. doi: 10.1007/s00277-002-0575-z. Epub 2002 Nov 29.
10
Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Leuk Res. 2001 Jul;25(7):603-25. doi: 10.1016/s0145-2126(01)00038-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验